Sector consensus Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Equities
600276
CNE0000014W7
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.10 CNY | -0.66% |
|
-5.52% | +0.89% |
| Jan. 12 | Hengrui Pharma Unit Secures Approval to Conduct Clinical Trial for Hypertension Drug | MT |
| Jan. 12 | Hengrui Pharma's Cancer Drug Obtains China Breakthrough Therapy Designation | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | CN¥82.86 | +37.87% | 17 | ||||||
| $1,110.72 | +2.99% | 28 | ||||||
| $216.21 | -0.83% | 24 | ||||||
| $245.22 | +13.45% | 27 | ||||||
| CHF 342.27 | -0.71% | 19 | ||||||
| GBX 204.34 | +14.04% | 20 | ||||||
| CHF 140.02 | -2.8% | 20 | ||||||
| DKK 400.99 | +7.26% | 21 | ||||||
| $114.93 | +3.43% | 27 | ||||||
| $331.59 | -3.49% | 27 | ||||||
| $134.53 | +4.2% | 26 | ||||||
| $28.66 | +10.69% | 24 | ||||||
| $500.4 | +8.51% | 25 | ||||||
| €100.96 | +28.78% | 22 | ||||||
| $56.96 | +4.51% | 23 | ||||||
| GBX 18.73 | +4.76% | 19 | ||||||
| ¥8,892.86 | +6.95% | 14 | ||||||
| ¥5,103.07 | +2.59% | 15 | ||||||
| €40.98 | -4.01% | 20 | ||||||
| Average | 950.86 | +7.27% | 22 | ||||||
| Weighted average by Cap. | 628.98 | +5.05% | 24 |
Select your edition
All financial news and data tailored to specific country editions
